Vistagen Therapeutics (VTGN) Receivables - Other (2021 - 2025)
Vistagen Therapeutics' Receivables - Other history spans 4 years, with the latest figure at $74000.0 for Q4 2025.
- For Q4 2025, Receivables - Other fell 50.34% year-over-year to $74000.0; the TTM value through Dec 2025 reached $74000.0, down 50.34%, while the annual FY2025 figure was $130000.0, 36.27% down from the prior year.
- Receivables - Other for Q4 2025 was $74000.0 at Vistagen Therapeutics, down from $92000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $380000.0 in Q2 2023 and bottomed at $40600.0 in Q1 2021.
- The 4-year median for Receivables - Other is $149000.0 (2024), against an average of $157130.8.
- The largest YoY upside for Receivables - Other was 30.96% in 2024 against a maximum downside of 51.05% in 2024.
- A 4-year view of Receivables - Other shows it stood at $44000.0 in 2021, then skyrocketed by 407.27% to $223200.0 in 2023, then crashed by 33.24% to $149000.0 in 2024, then crashed by 50.34% to $74000.0 in 2025.
- Per Business Quant, the three most recent readings for VTGN's Receivables - Other are $74000.0 (Q4 2025), $92000.0 (Q3 2025), and $111000.0 (Q2 2025).